Valeant buys Obagi, hits 52-week high


Valeant Pharmaceuticals International, Inc. (T.VRX) hit a new 52-week high of $77.70 Monday. Valeant Pharmaceuticals announced that the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 with respect to the previously announced tender offer by its indirect wholly-owned subsidiary, Odysseus Acquisition Corp., for all of the outstanding shares of common stock of Obagi Medical Products, Inc. at a price of $24.00 per share, net to the seller in cash, without interest (less any required withholding taxes) and subsequent merger of Purchaser with Obagi expired at 11:59 p.m., New York City time April 19, 2013. The expiration of the HSR waiting period satisfies one of the conditions to consummate the tender offer.

Empire Company Limited (T.EMP.A) hit a new 52-week high of $67.00 Monday. No news announcements today.

Molson Coors Canada Inc. (T.TPX.B) hit a new 52-week high of $53.75 Monday. No news announcements today.

Equity Financial Holdings Inc. (T.EQI) hit a new 52-week high of $10.95 Monday. No news announcements today.

Keyera Corp. (T.KEY) hit a new 52-week high of $59.82 Monday. No news announcements today.

Superior Plus Corp. (T.SPB) hit a new 52-week high of $12.95 Monday. No news announcements today.

Polaris Minerals Corporation (T.PLS) hit a new 52-week high of $1.20 Monday. No news announcements today.

Solium Capital Inc. (T.SUM) hit a new 52-week high of $4.19 Monday. No news announcements today.

Related Stories